Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Tamsulosin × 1 year × Clear all

Phase

Phase 1/2 1 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

pembrolizumab 257 Cyclophosphamide 243 Specimen Handling 194 fludarabine 169 Magnetic Resonance Spectroscopy 169 Biopsy 145 Nivolumab 132 Carboplatin 102 Radiotherapy 96 Paclitaxel 91 Gemcitabine 85 venetoclax 83 Cisplatin 82 fludarabine phosphate 80 Injections 74 Ipilimumab 67 Dexamethasone 65 Fluorouracil 60 atezolizumab 59 Radiation 59 Bevacizumab 58 Azacitidine 58 Cetuximab 57 Radiosurgery 54 durvalumab 53 Temozolomide 50 Oxaliplatin 48 Docetaxel 46 Rituximab 44 Leucovorin 44

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04147806 2026-04-03

PROSINT

Albert Einstein College of Medicine

Phase 1 Active not recruiting

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡